Top-Quality Turinabol Powder For Bodybuilding CAS:2446-23-3

    What Is Oral Turinabol?

    Oral Turinabol is a synthetic anabolic steroid developed in the early 1960s by the East German pharmaceutical company Jenapharm. Its creation was not accidental; it was part of State Plan 14.25, a covert program designed to give East German athletes an undisclosed competitive advantage on the world stage. For decades, thousands of Olympians and international competitors were administered Turinabol without their knowledge, a dark chapter in sports history that only came to light after the fall of the Berlin Wall.

    Structurally, Turinabol is a derivative of Dianabol (methandrostenolone) with a critical modification: the addition of a chlorine atom at the C4 position. This seemingly small alteration has profound implications. The chlorine substitution prevents the enzyme aromatase from converting the compound into estrogen, effectively eliminating the water retention and gynecomastia risk commonly associated with Dianabol. The result is a steroid that delivers anabolic effects without the estrogenic baggage.

    The C17-alpha alkylation-a methyl group added at the 17th carbon position-allows the compound to survive first-pass liver metabolism, making it orally bioavailable. This same modification, however, is responsible for the liver stress that accompanies all oral 17-alpha-alkylated steroids.

    When discussing top-quality Oral Turinabol powder, several distinguishing characteristics set premium product apart from inferior or contaminated material.

    Purity and Manufacturing Standards: Top-quality powder originates from pharmaceutical-grade synthesis or reputable underground laboratories that adhere to rigorous quality control. Impurities or byproducts from incomplete synthesis can introduce additional toxicity or unpredictable effects.

    Chemical Identity: Authentic Turinabol powder should appear as a fine, off-white to pale yellow crystalline substance. Its chemical formula-C20H25ClO2-and molecular weight of approximately 332.9 g/mol are consistent markers of legitimacy.

    Stable Blood Levels: Turinabol's pharmacokinetic profile supports relatively stable blood concentrations when properly dosed. Its half-life, discussed in detail later, allows for predictable accumulation and clearance.

    Anabolic-to-Androgenic Ratio: The compound exhibits a strongly anabolic profile with minimal androgenic activity. Some sources cite an anabolic-to-androgenic ratio exceeding 100:0, though precise figures vary across references. What matters practically is that Turinabol produces muscle-building effects without the harsh androgenic side effects seen in compounds like testosterone or Dianabol.

    Non-Aromatizing: As noted, the 4-chloro modification prevents aromatization entirely. Users do not experience estrogenic side effects-no bloating, no gynecomastia, no water retention. This feature alone makes Turinabol exceptionally attractive for bodybuilders seeking a dry, aesthetic physique.

    Turinabol occupies a versatile position in the bodybuilding toolkit. Its applications span multiple phases of training and competition preparation.

    Lean Bulking: Unlike Dianabol, which piles on rapid weight through a combination of muscle and water, Turinabol produces gradual, quality muscle gains. Users typically report improvements in muscle density and "hardness" rather than dramatic scale movements. This makes Tbol ideal for lean bulking cycles where the goal is adding contractile tissue without unwanted subcutaneous fluid.

    Cutting and Recomposition: The compound truly shines during caloric deficits. Turinabol helps preserve lean muscle mass while dieting-a critical function when the body is primed to catabolize muscle tissue for energy. Its lack of water retention means that as body fat decreases, the underlying muscle definition becomes increasingly visible.

    Strength Enhancement: Strength gains with Turinabol are steady and sustainable. They lack the dramatic spike associated with Dianabol or Anadrol, but they also lack the corresponding crash when the compound is discontinued. For athletes who need functional strength improvements without rapid weight fluctuations, Tbol offers a measured approach.

    Stacking Component: Experienced users frequently incorporate Turinabol as part of multi-compound cycles. It pairs effectively with injectable testosterone bases, serving as a kickstarter in the early weeks of a longer cycle while waiting for longer-acting esters to reach steady-state concentrations. It can also be positioned at the end of a cycle to solidify gains and enhance definition before transitioning to post-cycle therapy.

    The benefits of Oral Turinabol are numerous, which explains its enduring popularity despite the availability of newer compounds.

    Clean, Dry Gains: Perhaps the most celebrated benefit is the quality of muscle tissue produced. Gains are lean, dense, and devoid of the puffy, water-logged appearance that plagues users of aromatizing steroids. The resulting physique appears harder and more defined.

    No Estrogenic Side Effects: The absence of aromatization means no gynecomastia, no water retention, and no need for aromatase inhibitors during the cycle. This simplifies cycle management and reduces the number of ancillary compounds required.

    Mild Androgenic Profile: Compared to many other AAS, Turinabol's androgenic effects are relatively subdued. Users typically report fewer androgenic side effects such as acne, accelerated hair loss, or prostate irritation.

    Muscle Preservation: During cutting phases, Turinabol's anti-catabolic properties help maintain hard-earned muscle tissue. This is particularly valuable when calories are restricted and training volume remains high.

    SHBG Modulation: Turinabol has been shown to reduce sex hormone-binding globulin (SHBG), allowing more free testosterone to remain biologically active. This effect can enhance the efficacy of other concurrently administered androgens.

    Gradual, Sustainable Progress: Unlike compounds that produce rapid but often transient results, Turinabol's effects accumulate steadily over the course of a cycle. Gains made on Tbol tend to be more maintainable post-cycle.

    Dosing Turinabol requires careful consideration of experience level, goals, and individual response. The following guidelines represent general consensus drawn from anecdotal reports and practical experience.

    Beginners: Novice male users typically start in the range of 30–40 mg per day. This dose provides noticeable anabolic effects while keeping side effect risks manageable. Some sources suggest even lower starting points of 20–30 mg for those particularly sensitive or cautious.

    Intermediate Users: Those with prior AAS experience often increase to 40–60 mg daily. At this range, the anabolic effects become more pronounced, and users report meaningful improvements in muscle density and strength.

    Advanced Users: Experienced bodybuilders may push doses to 60–80 mg or occasionally higher. However, doses exceeding 80–100 mg per day are generally discouraged due to escalating liver toxicity and diminishing returns. The risk-to-reward ratio becomes unfavorable beyond this threshold.

    Female Users: Women considering Turinabol should exercise extreme caution. Recommended doses range from 5–15 mg per day. At these levels, virilization symptoms are less likely, though the risk never entirely disappears. Female athletes should be particularly vigilant about monitoring for signs of masculinization.

    Dosing Frequency: Due to Turinabol's half-life, splitting the daily dose into two administrations-approximately 8–12 hours apart-helps maintain stable blood levels and optimize anabolic effects. Morning and evening dosing is a common and practical approach.

    The structure of a Turinabol cycle significantly influences both results and safety.

    Cycle Length: Most authorities recommend cycles of 6–8 weeks. This duration allows sufficient time for the compound to exert its anabolic effects while limiting cumulative liver stress. Extending beyond eight weeks increases the likelihood of elevated liver enzymes and other adverse outcomes.

    Typical Cycle Outline:

    ●Weeks 1–6 or 1–8: Turinabol administered daily at the chosen dose, split into two equal administrations.

    ●Support Supplements: During the cycle, users often employ liver support agents (milk thistle, N-acetylcysteine, TUDCA), cardiovascular support (omega-3 fatty acids, CoQ10), and lipid management strategies.

    ●Testosterone Base: Many users incorporate a testosterone ester (e.g., Testosterone Enanthate or Cypionate at 300–500 mg weekly) as a base to maintain normal physiological function and prevent suppression-related symptoms. Turinabol suppresses endogenous testosterone production, and running it without a testosterone base can lead to lethargy, diminished libido, and other hypogonadal symptoms.

    Kickstarting: Turinabol's rapid onset of action makes it an effective kickstarter for longer cycles. Users may run Tbol for the first 4–6 weeks of a 12–16 week injectable cycle, discontinuing the oral once the injectable compounds have reached full effect.

    End-of-Cycle Positioning: Alternatively, some users place Turinabol at the end of a cycle to "harden" gains and enhance definition before transitioning to PCT.

    Understanding Turinabol's half-life is essential for optimal dosing and cycle planning.

    Half-Life Duration: The half-life of Oral Turinabol is approximately 16 hours. However, some sources cite shorter figures in the range of 7–9 hours. This variability likely reflects individual metabolic differences and the limitations of available pharmacokinetic data.

    Dosing Implications: A 16-hour half-life means that after 16 hours, approximately half the administered dose remains in circulation. Splitting the daily dose into two administrations-roughly 8–12 hours apart-helps maintain more consistent blood concentrations throughout the day. This stability may enhance anabolic signaling and reduce the peaks and troughs that can contribute to side effects.

    Detection Time: One of Turinabol's most notorious characteristics is its exceptionally long detection window. The compound's metabolites can be identified in urine for months or even years after discontinuation. This presents a significant risk for athletes subject to anti-doping testing and explains why positive tests for DHCMT metabolites continue to surface years after the drug was supposedly discontinued.

    Clearance and PCT Timing: Because Turinabol is an oral compound with a relatively short half-life, post-cycle therapy can begin relatively quickly after the last dose-typically within 3–4 days. This contrasts with long-acting injectable esters that may require a 2–3 week waiting period before initiating PCT.

    Post-cycle therapy is not optional following a Turinabol cycle. The compound suppresses endogenous testosterone production, and PCT is essential to restore normal hypothalamic-pituitary-gonadal axis function.

    PCT Timing: Begin PCT approximately 3–4 days after the final Turinabol dose. If the cycle included a testosterone base with a long ester, PCT should be delayed until the ester has cleared-typically 2–3 weeks after the last injection.

    Common PCT Protocols:

    ●Nolvadex (Tamoxifen) Only: A common approach involves Nolvadex at 40 mg daily for the first two weeks, followed by 20 mg daily for an additional two weeks.

    ●Clomid (Clomiphene) Only: Clomid at 50 mg daily for 3–4 weeks represents another straightforward option.

    ●Combination Therapy: Some users combine both SERMs for potentially enhanced recovery. A typical combination protocol might include Clomid at 50 mg and Nolvadex at 20 mg daily for 4 weeks.

    Supportive Measures: During PCT, additional supportive measures may include natural testosterone boosters, adequate sleep, stress management, and continued training to maintain gains. HCG (human chorionic gonadotropin) is sometimes employed at the end of a cycle and before PCT to stimulate testicular function, though its use requires careful timing to avoid further suppression.

    Monitoring Recovery: Blood work is strongly recommended to confirm that natural testosterone production has returned to baseline. Without objective data, users are essentially guessing about their recovery status.

    No discussion of Turinabol would be complete without acknowledging its risks.

    Hepatotoxicity: As a C17-alpha-alkylated oral steroid, Turinabol imposes stress on the liver. Elevated liver enzymes are common during cycles, and prolonged or high-dose use carries the risk of more serious liver injury. Regular blood work during and after cycles is essential for monitoring liver health.

    Cardiovascular Effects: Turinabol can negatively impact lipid profiles, reducing HDL (good cholesterol) and increasing LDL (bad cholesterol). This effect is dose-dependent and may contribute to long-term cardiovascular risk.

Trade names	Oral Turinabol,4-Chloro-17α-methyl-17β-hydroxy-1,4-androstadien-3-one
CAS	2446-23-3
Molar mass	334.88
Formula	C20H27ClO2
Purity	Above 98%
Apprarance	White crystalline powder

 

 

Any needs, please contact us

Email: Jasonraws106@gmail.com

WhatsApp: +86-15572565525
Telegram: +86-15871669785

   

                                  

 

    Oral Turinabol powder occupies a distinctive position in the bodybuilding world-a compound with a dark past but enduring appeal for those seeking clean, quality muscle gains without the estrogenic baggage of other orals. Its gradual, sustainable effects, mild androgenic profile, and versatility across bulking and cutting phases have earned it a loyal following among experienced users.

Hot Tags: top-quality turinabol powder for bodybuilding cas:2446-23-3, China top-quality turinabol powder for bodybuilding cas:2446-23-3 manufacturers, suppliers, factory, Anabolic steroid drugs DHT, Anastrozole, Methandienone, Nandrolone Decanoate, Nandrolone Phenypropionate, Quality Bodybuilding Products Sustanon